Novartis Ag (NVS) Interest & Investment Income (2013 - 2014)
Novartis Ag (NVS) posted Interest & Investment Income of $33.0 million for Q4 2014, down 2.94% sequentially from $34.0 million in Q4 2013, and down 2.94% YoY from $34.0 million in Q4 2013.
Novartis Ag (NVS) Interest & Investment Income (2013 - 2014) Analysis & Trends
Novartis Ag has reported Interest & Investment Income for 2 years, with the latest figure at $33.0 million in Q4 2014.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Int & Inv Inc (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 652.20 Bn | 631.44 Bn | 17.26 Bn | 219.00 Mn |
| 2 | AbbVie | 469.51 Bn | 462.94 Bn | 12.70 Bn | -679.00 Mn |
| 3 | Merck | 376.81 Bn | 369.67 Bn | 12.21 Bn | - |
| 4 | Novartis Ag | 303.04 Bn | 295.35 Bn | 11.24 Bn | - |
| 5 | Astrazeneca | 257.61 Bn | 252.71 Bn | 12.86 Bn | 80.00 Mn |
| 6 | Amgen | 237.37 Bn | 223.38 Bn | 7.24 Bn | - |
| 7 | Gilead Sciences | 181.73 Bn | 178.55 Bn | 6.22 Bn | - |
| 8 | Pfizer | 159.66 Bn | 147.96 Bn | 10.94 Bn | - |
| 9 | Gsk | 106.24 Bn | 102.07 Bn | 8.24 Bn | 77.82 Mn |
| 10 | Sanofi | 55.07 Bn | 47.69 Bn | 10.79 Bn | 89.50 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2014 | 33.00 Mn |
| Dec 31, 2013 | 34.00 Mn |